Zhang, N. ., Zhang, G. ., Liu, N. ., Lin, W. ., Ji, S. ., Zheng, M. ., … Yang, S. . (2017). A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models. Oncotarget, 8(67), 111495-111507. https://doi.org/10.18632/oncotarget.22847 (Original work published 2017)